Correlation Between Global Unichip and GeneReach Biotechnology

Can any of the company-specific risk be diversified away by investing in both Global Unichip and GeneReach Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Global Unichip and GeneReach Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Global Unichip Corp and GeneReach Biotechnology, you can compare the effects of market volatilities on Global Unichip and GeneReach Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Global Unichip with a short position of GeneReach Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Global Unichip and GeneReach Biotechnology.

Diversification Opportunities for Global Unichip and GeneReach Biotechnology

-0.59

Correlation Coefficient

Global Unichip  GeneReach Biotechnology

Excellent diversification

The 3 months correlation between Global and GeneReach is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding Global Unichip Corp and GeneReach Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GeneReach Biotechnology and Global Unichip is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Global Unichip Corp are associated (or correlated) with GeneReach Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GeneReach Biotechnology has no effect on the direction of Global Unichip i.e., Global Unichip and GeneReach Biotechnology go up and down completely randomly.

Pair Corralation between Global Unichip and GeneReach Biotechnology

Assuming the 90 days trading horizon Global Unichip Corp is expected to generate 1.56 times more return on investment than GeneReach Biotechnology. However, Global Unichip is 1.56 times more volatile than GeneReach Biotechnology. It trades about 0.07 of its potential returns per unit of risk. GeneReach Biotechnology is currently generating about -0.07 per unit of risk. If you would invest  122,500  in Global Unichip Corp on October 6, 2024 and sell it today you would earn a total of  4,500  from holding Global Unichip Corp or generate 3.67% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Global Unichip Corp  vs.  GeneReach Biotechnology

Global Unichip Corp

Risk-Adjusted Performance

6 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Global Unichip Corp are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Global Unichip showed solid returns over the last few months and may actually be approaching a breakup point.

GeneReach Biotechnology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GeneReach Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's basic indicators remain stable and the latest fuss on Wall Street may also be a sign of long-term gains for the venture sophisticated investors.

Pair Trading with Global Unichip and GeneReach Biotechnology

The main advantage of trading using opposite Global Unichip and GeneReach Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Global Unichip position performs unexpectedly, GeneReach Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GeneReach Biotechnology will offset losses from the drop in GeneReach Biotechnology's long position.

The idea behind Global Unichip Corp and GeneReach Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.